Krystal Biotech, Inc. (KRYS)

272.50 +5.60 (+2.10%) USD  |  NASDAQ  |  Feb 25, 16:00
273.60 +1.10 (+0.40%) After-Hours: 07:55
More

Krystal Biotech Change in Receivables (TTM)

Change in Receivables (TTM) Chart

View Change in Receivables (TTM) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (TTM) Range, Past 5 Years

View Change in Receivables (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (TTM) Benchmarks

View Change in Receivables (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
DexCom, Inc. Upgrade
Alkermes Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade